These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34187471)

  • 21. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.
    Aghaei AM; Gholami J; Sangchooli A; Rostam-Abadi Y; Olamazadeh S; Ardeshir M; Baheshmat S; Shadloo B; Taj M; Saeed K; Rahimi-Movaghar A
    Lancet Glob Health; 2023 Aug; 11(8):e1225-e1237. PubMed ID: 37474230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern.
    Michel L; Lions C; Van Malderen S; Schiltz J; Vanderplasschen W; Holm K; Kolind T; Nava F; Weltzien N; Moser A; Jauffret-Roustide M; Maguet O; Carrieri PM; Brentari C; Stöver H
    BMC Public Health; 2015 Oct; 15():1093. PubMed ID: 26507505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventions to reduce HIV transmission related to injecting drug use in prison.
    Jürgens R; Ball A; Verster A
    Lancet Infect Dis; 2009 Jan; 9(1):57-66. PubMed ID: 19095196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review.
    Colledge-Frisby S; Ottaviano S; Webb P; Grebely J; Wheeler A; Cunningham EB; Hajarizadeh B; Leung J; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Degenhardt L
    Lancet Glob Health; 2023 May; 11(5):e673-e683. PubMed ID: 36996860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study.
    Roux P; Donadille C; Magen C; Schatz E; Stranz R; Curado A; Tsiakou T; Verdes L; Aleksova A; Carrieri P; Mezaache S; Charif Ali B;
    Int J Drug Policy; 2021 Jan; 87():102992. PubMed ID: 33096364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injecting substance use in prisons in the United States: a case for needle exchange programs.
    Armstrong-Mensah E; Dada D; Rupasinghe R; Whately H
    Am J Drug Alcohol Abuse; 2021 May; 47(3):273-279. PubMed ID: 33596124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services.
    Getahun H; Gunneberg C; Sculier D; Verster A; Raviglione M
    Curr Opin HIV AIDS; 2012 Jul; 7(4):345-53. PubMed ID: 22678489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of medical and substance use co-morbidities in Central Asian prisons: implications for HIV prevention and treatment.
    Vagenas P; Azbel L; Polonsky M; Kerimi N; Mamyrov M; Dvoryak S; Altice FL
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S25-31. PubMed ID: 23932844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harm reduction: a public health approach to prison drug use.
    Belisle LA; Solano-Patricio EDC
    Int J Prison Health; 2022 Nov; 18(4):458-472. PubMed ID: 34962726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
    Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
    Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Principles of condom provision programs in prisons from the standpoint of European prison health experts: a qualitative study.
    Moazen B; Mauti J; Meireles P; Černíková T; Neuhann F; Jahn A; Stöver H
    Harm Reduct J; 2021 Jan; 18(1):14. PubMed ID: 33509200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis.
    Stone J; Degenhardt L; Grebely J; Larney S; Altice FL; Smyrnov P; Rahimi-Movaghar A; Alavi M; Young AM; Havens JR; Miller WC; Hickman M; Vickerman P
    Lancet Psychiatry; 2021 Apr; 8(4):301-309. PubMed ID: 33640039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
    Grebely J; Dore GJ; Morin S; Rockstroh JK; Klein MB
    J Int AIDS Soc; 2017 Jul; 20(1):22146. PubMed ID: 28782335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
    Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
    Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
    Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
    Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
    Krug A; Hildebrand M; Sun N
    J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction.
    Meyer JP; Culbert GJ; Azbel L; Bachireddy C; Kurmanalieva A; Rhodes T; Altice FL
    Harm Reduct J; 2020 Oct; 17(1):86. PubMed ID: 33129341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland.
    Fraser H; Mukandavire C; Martin NK; Goldberg D; Palmateer N; Munro A; Taylor A; Hickman M; Hutchinson S; Vickerman P
    Addiction; 2018 Nov; 113(11):2118-2131. PubMed ID: 29781207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome assessment of a triangular clinic as a harm reduction intervention in Rajaee-Shahr Prison, Iran.
    Asl RT; Eshrati B; Dell CA; Taylor K; Afshar P; Kamali M; Mirzazadeh A
    Harm Reduct J; 2013 Dec; 10():41. PubMed ID: 24369092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.